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Abstract
Background: African countries are underrepresented in cancer research, partly because of a lack of structured curricula on clinical research
during medical education. To address this need, the MD Anderson and Zambia Virtual Clinical Research Training Program (MOZART) was developed jointly by MD Anderson Cancer Center (MDA) and the Cancer Diseases Hospital in Zambia (CDH) for Zambian clinical oncology trainees.
We explored participant perspectives to provide insight for implementation of similar efforts.
Materials and Methods: The MD Anderson and Zambia Virtual Clinical Research Training Program consisted of weekly virtual lectures and support of Zambian-led research protocols through longitudinal mentorship groups that included CDH faculty and MDA peer and faculty mentors.
Participants were contacted via email to take part in semi-structured interviews, which were conducted via teleconference and audio-recorded,
transcribed, and coded. Emergent themes were extracted and are presented with representative verbatim quotations.
Results: Thirteen of the 14 (93%) trainees were interviewed. Emergent themes included (1) participants having diverse educational backgrounds
but limited exposure to clinical research, (2) importance of cancer research specific to a resource-constrained setting, (3) complementary roles of
peer mentors and local and international faculty mentors, (4) positive impact on clinical research skills but importance of a longitudinal program
and early exposure to clinical research, and (5) challenges with executing research protocols.
Conclusion: To our knowledge, this is the first qualitative study of African clinical oncology trainees participating in a virtual clinical research
training program. The lessons learned from semi-structured interviews with participants in MOZART provided valuable insights that can inform
the development of similar clinical research training efforts and scale-up.
Key words: clinical research; training program; virtual; oncology; international; Africa.

Implications for Practice
The MD Anderson and Zambia Virtual Clinical Research Training Program is a fully virtual, international partnership to provide clinical
research training for Zambian clinical oncology trainees. Participants’ perspectives were studied through semi-structured interviews.
Participants expressed both interest in and understanding of the need for clinical research specific to their resource-constrained practice
environments. International peer mentorship was uniquely beneficial and may increase the capacity for research mentorship. Challenges
encountered in learning about and performing clinical research demonstrated the importance of a longitudinal program and early exposure
to clinical research. These lessons can be applied to the implementation and scale-up of similar efforts throughout Africa.

Introduction
African countries are experiencing a rapid increase in cancer
burden but are underrepresented in cancer research for numerous reasons, including a lack of structured training in clinical

research during medical education.1 Training local physicians
in clinical research methods is a potentially scalable and sustainable solution to the shortage of clinical research productivity.2 The development of virtual educational partnerships
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Materials and Methods
Program Structure
The first group of trainees in the CDH clinical oncology
program enrolled in this 4-year program in 2018. All CDH
clinical oncology trainees were required to attend MOZART
as this was integrated as a formal part of their training curriculum. There was no competitive application process. The
pilot clinical research training program took place between
August 2020 and July 2021. The didactic curriculum included
lectures on developing mentor relationships, identifying a
research question, evaluating a research paper, research types
and study design, institutional review boards (IRBs) and
research ethics, biostatistics, scientific writing, and clinical

trial design, among others. This was followed by a period of
longitudinal research mentorship (Fig. 1).
The trainees initially identified an area of research interest with their local CDH faculty mentor and were thereafter
paired with peer resident or fellow mentors and faculty mentors at MDA. A total of 6 peer mentors and 6 international
faculty mentors from MDA participated. The peer mentors
were selected based on interest in global health, mentorship,
and prior clinical research experience and all of them had at
least one first author, peer-reviewed publication. Trainees and
mentors were encouraged to meet at least once every 3 weeks
via teleconference.

Study Design
To explore participants’ perspectives about the program, we
used a qualitative study design. The study was approved by
the IRB at MDA. All participants were contacted via email to
take part in a semi-structured interview and provided verbal
informed consent to participate. Participants were not offered
compensation. The semi-structured interviews were conducted via teleconference between June 2021 and September
2021 by a single member of the team (N.A.) from MDA who
had not participated in the lecture series or previously interacted with the participants. With the permission of the interviewees, the interviews were audio recorded and manually
transcribed. Data collection ended when all participants had
been interviewed or declined to be interviewed.
The semi-structured interview guide was developed with
input from both CDH and MDA investigators (Table 1).
Thematic analysis of the transcripts from these interviews was
used to examine patterns and relationships between themes
and subthemes with the assistance of the qualitative data
analysis software ATLAS.ti (version 9, Berlin, Germany). Each
transcript was double-coded by 2 co-authors (K.D., D.A.K.)
with the interview guide, and any differences were resolved
through discussion.5,6 Emergent themes were extracted and
are presented below, with representative verbatim quotations.

Results
All 14 CDH clinical oncology trainees participated in
MOZART, and of these, 13 (93%) agreed to be interviewed.
Of the 13 interviewees, 7 were women and 6 were men, and
the median age was 34 years (range, 30-49). Five were in their
2nd year, 4 third year, and 4 were in their fourth year of training. Primary languages spoken were English (8) and other
languages (9) including Bemba, Nyanja, Tok Pisin, Sotho,

Figure 1. Schematic timeline of the MD Anderson and Zambia Virtual Clinical Research Training Program (MOZART).
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between academic medical centers with strong clinical
research infrastructure and resource-constrained centers in
low- and middle-income countries (LMICs) will be important to address this need, especially as models of collaboration
shift to a virtual format as an adaptation to the COVID-19
pandemic.3 Building on an existing academic partnership,4
The University of Texas MD Anderson Cancer Center (MDA)
and the Cancer Diseases Hospital in Zambia (CDH) developed a joint virtual clinical research education program
for Zambian clinical oncology trainees, known as the MD
Anderson and Zambia Virtual Clinical Research Training
Program (MOZART). This program consists of weekly virtual lectures from content experts at MDA and CDH and support of Zambian-led research protocols through longitudinal
mentorship.
Virtual instruction in clinical research for African clinical
oncology trainees may increase training capacity and longitudinal partnerships while reducing costs associated with implementation, but the benefits and challenges of such a program
have not been explored from the participants’ perspective,
which should be considered when designing an effective curriculum. International peer mentorship may be an important
component of expanding clinical research mentorship capacity, but differences in peer versus faculty mentorship and local
versus international mentorship have not been studied in
this context. This information could be uniquely valuable in
designing and improving future clinical research training initiatives in Africa. In this study, we explored the perspectives
of participants in MOZART through semi-structured interviews with the goal of refining the program and providing
recommendations for implementation and scale-up of similar
efforts.
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Table 2. Zambian fellow-led research project titles.

A. Demographics

Assessing the patterns of presentation and management of pediatric
brain tumor patients at the Cancer Diseases Hospital.

 1. What year in your training program are you?
 2. What is your primary spoken language?
 3. What is your primary written language?

Epidemiological and clinical characteristics of oropharynx cancer at
Cancer Diseases Hospital.

 1. Can you tell me about your educational background?

Comparing the role of induction chemotherapy followed by concurrent chemoradiotherapy versus chemoradiotherapy alone in the
treatment of patients with locally advanced nasopharyngeal cancer at
Cancer Diseases Hospital.

 2. How would you describe your familiarity with clinical research
prior to the clinical research course?

Retrospective review of conjunctival squamous cell carcinoma at
Cancer Diseases Hospital.

 3. Can you tell me about any specific previous experiences with
clinical research before taking part in the clinical research course?

The effect of delaying radiotherapy on local recurrence and survival in
patients with stage III Wilms Tumor at Cancer Diseases Hospital.

C. Experience with lectures

Retrospective evaluation of toxicity outcomes for 2D versus 3D planning for locally advanced cervical cancer brachytherapy.

 4. What country were you born in?
B. Prior clinical research experiences

 1. In general, when you go to a lecture that’s very helpful to you,
what is that like?
 2. What did you hope to gain from participating in the clinical
research course?
 3. How do you think clinical research will be relevant to your
future career?
 4. Can you describe your experience participating in the lectures?
 5. What topics do you feel needed either more or less attention
during the course?
 6. In what ways should the registrars engage with the material?
D. Application of course to research
 1. How did the course prepare you to conduct your own clinical
research?
 2. What are some specific examples of how you applied what you
learned in the course to your own research?
 3. In what ways did you feel unprepared to conduct your own
clinical research?

Measuring the overall benefit of 3D planning for breast radiotherapy
in a resource-limited environment.
Overall survival and outcomes in geriatric cancer patients at Cancer
Diseases Hospital.
Retrospective study to evaluate the causes of mortality for cervical
cancer patients during chemoradiotherapy and within the acute period
of treatment completion.
A retrospective study of de novo metastatic breast cancer incidence
and overall survival: Does sociodemographic play a role in late presentation?
A retrospective study to establish why pediatric patients with retinoblastoma present with advanced disease at Cancer Diseases Hospital.
The influence of time from preoperative chemoradiation to surgery on
rectal cancer patients at Cancer Diseases Hospital.
Corrigendum of FIGO staging and its impact on management of
cervical carcinoma at Cancer Diseases Hospital.

 4. What aspects of the course were not as helpful?
 5. How could these aspects be made more relevant for you?
E. Experience with mentorship
 1. What are the characteristics of good mentorship relationships, in
your opinion?
 2. Tell me about your mentorship experience in the program.
 3. How have your mentorship relationships helped you to develop
your research protocol?
 4. What challenges have you experienced along the way?
 5. What things could a mentor do to help you with that challenge?
 6. In what ways was your relationship with your peer mentor and
faculty mentors different?
 7. How did you view their roles as part of your research team?
 8. How do you view the different role and relationships you have
with your local and international (MD Anderson) mentors?
F. Conclusions

average number of virtual meetings per mentorship group
was 10 meetings over 8 months. However, mentorship was
also provided outside of planned meetings such as via email
and mobile apps, and peer mentors estimated that they provided an average of 18 h of mentorship time over 8 months.
Zambian fellow-led research project titles are summarized in
Table 2.
Emergent themes from interviews included (1) diverse
educational backgrounds but lack of exposure to clinical
research, (2) the importance of cancer research specific to a
resource-constrained setting, (3) complementary roles of peer
mentors and local and international faculty mentors, 4) positive impact on clinical research skills but importance of a longitudinal program, and (5) challenges with research protocol
execution.

 1. What do you think other oncology trainees should know about
this course?

Diverse Educational Backgrounds but Lack of
Exposure to Clinical Research

 2. Can you explain why you would or would not recommend the
course?

Many of the trainees in this program completed their medical
training in countries other than Zambia, such as China, Cuba,
Russia, Sierra Leone, Democratic Republic of the Congo,
Malawi, and Papua New Guinea. Some started the clinical
oncology program immediately after completing their internship
and rural postings, but others worked as practicing physicians
for more than a decade before applying to the program.
Despite these differences in educational background, trainees had not been exposed to clinical research curricula in their
prior programs, and mostly lacked experience in participating in clinical research projects. One trainee had published a
peer-reviewed case report as a middle author. One of the main
reasons identified for the lack of exposure to clinical research

 3. Would participating in the clinical research course again next
year be useful?
 4. Is there anything else that you would like to comment on about
the clinical research course that we have not discussed today?

Pidgin English, and French. Primary written languages were
English (12) and other languages (3) including Nyanja, Sotho,
and French. Birth/home countries were Zambia (7) and other
countries (6) including Sierra Leone, Malawi, Papua New
Guinea, Lesotho, and Democratic Republic of the Congo. The

Downloaded from https://academic.oup.com/oncolo/advance-article/doi/10.1093/oncolo/oyac110/6605790 by M. D. Anderson Cancer Center - Research Medical Library user on 12 July 2022

Table 1. Semi-structured interview guide.

The Oncologist, 2022, Vol. XX, No. XX

4

There was a study that I participated in, as in it was just
mostly data collection and things like that. It was not really the depth of the whole research and the writing, but
mostly just assisting with data collection.
I wouldn’t say much experience, because during internship we don’t do anything of the kind, it’s more of like
practicing [medicine]… So when I came to oncology that
was the best experience with actually doing research. I
would say I never did any until now when I came to clinical oncology.

For most of the trainees, participating in MOZART was both
their first exposure to a clinical research curriculum and their
first experience participating in a clinical research project.
I just didn’t know much about research and things like
that because really it wasn’t part of our program in school
during undergrad. There was nothing, we didn’t have
courses on clinical research.

Importance of Cancer Research Specific to a
Resource-Constrained Setting
All the trainees felt that clinical research was important for
a variety of reasons, including the need for systematic investigation of therapies, communication of scientific findings,
advancement of medicine, ability to influence policymakers
and policy implementation, and ultimately better patient care.
However, the most mentioned reason was that existing published research is heavily skewed toward high-income countries and does not necessarily represent resource-constrained
practice environments and particular patient populations.
The trainees recognized that they did not have access to certain standard-of-care treatments, and research and evidence
to guide their clinical decision-making when it deviated from
established norms was lacking.

At the moment we only have 3 practicing clinical oncologists in [my country], so there are a lot of things that
we don’t know about our own population that need a lot
more research… Most of it, we extrapolate from data from
neighboring countries. We are going to need this information even in my own career.
[My country] does not have a cancer center. We are going to be the first team to establish a cancer facility in [my
country], so it means that it is a fertile land on which we
can learn more on clinical research. So the experience in
research would be for me a very important component in
my training so that when I move back home I should be
in a position to contribute to knowledge in the continent
and in the field of research.

Complementary Roles of Peer Mentors and Local
and International Faculty Mentors
The trainees described a good mentor as someone who is
accessible, has open lines of communication, sufficient time
to spend with the trainee, and can provide material resources
and guidance for their research projects. The trainees were
particularly positive about the impact of the close working
relationships they had developed with their MDA peer mentors. They spent the greatest amount of time working oneon-one with their peer mentors, who they found to be more
accessible because of their somewhat less busy schedules and
more open lines of communication through mobile devices.
With the support of their peer mentor, the trainees would
work on their research projects and then at longer intervals
convene with the entire mentorship team, including faculty
mentors, for additional feedback and guidance.
The peer mentor relationship was very good and accessible
because we even set up a WhatsApp to which we could
drop information to say can we have a meeting tomorrow.
It was not too complicated, not too formal. We would have
our discussions first even before the consultants join our
meeting, like “correct this” or “correct that”.
I feel like the peer mentor would understand me. The
peer mentor probably would have more time to have calls
almost all the time as compared to my faculty mentors. My
faculty mentors are busy people so I don’t think they have
as much time as I would want with them.
[My peer mentor] has been there for me from the start.
At times she even asked about my personal life. I had
COVID and during that time she was even communicating
with me asking how I was doing.

Yes, I think it will be so interesting [to do my own research]. For me I really want to know what exactly is happening because the conditions are different, us being in a
low resource environment we don’t have this or have that
and the standard protocol has everything. So it would be
helpful to know what is really working and what is going
on in our resource-constrained environment.
We really need clinical research because most of the
time, I’ll speak for Zambia, we don’t have much research.
We rely on data that is in the Western world, which may
not necessarily be the same for us because we have different experiences. It’s important that we have research and I
would like to be part of research so we can answer questions and be able to manage our patients better.

The trainees also found it helpful to have a local faculty mentor with whom they could interact with quickly and in person, and who also understood the complexities and feasibility
of doing research in their system. The MDA faculty mentors
provided guidance on how to ask important and interesting
research questions and refining project aims and methods.

Trainees who were born in countries outside Zambia were
motivated by a strong desire to bring their clinical research
skills back to their home countries, which typically had very
little cancer care infrastructure. They expressed excitement at
the prospect of being able to generate and apply data from
patients in their own countries to advance patient care locally
and were eager to be among the first do so.

With my local mentor, the fact that she’s here within even
as I’m doing the work. Sometimes I just pitch in and I have
a question in mind I actually just get to ask her. So for the
local mentor it’s easier, she’s always there.
My international mentor is able to give me a broader aspect as to how I can go about things and it marries in with
my local mentor. My local mentor has the experience of
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was a focus on clinical education during prior training and
a lesser emphasis on research in general medicine than in
oncology.
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Impact on Clinical Research Skills and Importance
of a Longitudinal Program
The trainees felt that a research curriculum was just as essential to their training as the clinical curriculum. They described
a stark contrast in their clinical research preparedness before
and after participating in MOZART, developing an appreciation for the structured process of research through the
program.
I think they need to protect [ie, maintain and support the
clinical research training program]. I would recommend
that everyone take this. It’s a great opportunity, it builds
confidence. It’s a platform for one to stand on their feet
in research.
Going into the course I was naïve, but after the course
I was able to carry out my dissertation project. I was able
to find a topic to write on and how to go about getting
permission to carry out the research.
It was a clear step by step process that helped us understand how to develop these research questions and how to
take it all the way through the methodology, results, and
how to analyze them into a compete research paper.

However, trainees were realistic in recognizing that much
remained to be learned, and they felt that either a longer
course or participating again would fill in some of the persistent gaps in their knowledge. Specifically, they found their
training in biostatistics to be inadequate, as it consisted of
only a single lecture. The more senior trainees wished that
the curriculum had been implemented earlier during their
training.
I feel obviously it helped because it went from not knowing
anything to something, but I feel like I would still need
more lectures to fully get exactly what research is.
There are some parts that I felt needed more light especially where it talked about how to calculate the sample
size. There are some parts where you need the help of the
biostatistician, but even before they come in at least we
should be able to understand these issues, such as how to
interpret results and how do you calculate the p-value.
I wish I would have had this [research course] in my first
year, I think it would have helped me develop my research
topic earlier and I would have even gotten a better understanding if this was something that I was coming back to
every now and then… But that is something that people in
the other years will get to experience.

Challenges With Execution of Research Protocols
The trainees noted several challenges in progressing with their
research protocols. They were balancing a full clinical load
and exams and felt that they needed more protected time for
research. Many of the trainees had experienced personal illness including contracting COVID-19 and were dealing with
prolonged recovery from their ailments. Performing literature

reviews was difficult without access to paid subscription
journals. Data retrieval was also a barrier, because medical
records are handwritten, often lack a uniform standard of
documentation, and are prone to being lost in storage.
That for me has been the biggest challenge, finding time to
actually sit and work on my research. If we could get even
a free 2 hours at work where it is research time where you
can just sit [and work on research].
I got COVID so during that period it was very difficult
for me to actually meet with my mentor. So I lost some
time from my mentoring situation.”
The main challenge I’m facing right now is getting data.
There was a switch from the main hospital to the cancer
hospital for the pediatric patients, and during that shift
most of the data was misfiled… So we had to change the
time period for my research.
Because I had thought the process had taken just too
long, the lack of communication on my part may have
breached my relationships with the peer mentor… maybe
the part that I was supposed to do was to keep telling them
that I have challenges collecting the information, it’s difficult to find the files. Reporting the same thing every day
was getting to be a challenge. But we ended up going ahead
with the information that we could collect.

Discussion
Semi-structured interviews with participants in MOZART
provided valuable insights into the scope of the trainees’
educational backgrounds and their plans for incorporating
research into their future careers, the need for research conducted in a resource-constrained environment, the unique
roles held by different types of mentors (peer vs. faculty, local
vs. international) in professional development, the importance of a longitudinal training program with early exposure
to clinical research, and challenges associated with conducting trainee-led research in their work environment. To our
knowledge, this is the first qualitative study of the perspectives of African clinical oncology trainees participating in a
virtual clinical research training program. The findings from
this study can inform the development of similar clinical
research training efforts and scale-up elsewhere.
Despite the diversity in medical education from countries
around the globe, none of the participants in this study had
received formal education in clinical research, and very few
had participated in clinical research. This reflects an unmet
need for clinical research training, including oncology-specific
clinical research, in the region as supported by a recent survey
of trainees and recent graduates of a Tanzanian clinical oncology program showing that only 23% reported prior research
experience, 37% formal training in research methodology,
and 13% research mentorship.7 The same study found that
87% of respondents intended to incorporate research into
their future careers.
Our findings from the current study are similar. Because
MOZART is a formal part of the Zambian clinical oncology curriculum, there was no competitive application process.
Among this unselected group of trainees, there was a strong
perception of the importance of clinical research. The trainees further perceived that existing published research is heavily skewed to high-income countries, the results of which do
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some of the limitations here that I may not know of. While
getting an idea from my international mentor, which is
great, my local mentor will build on that or be able to tell
my international mentor ‘this is not feasible in my environment’, or ‘we could do this’, so it’s important to have both.

5
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doctoral theses, peer-reviewed publication output, and success applying for grant funding demonstrates the potential
impact of these types of partnerships. MOZART is novel and
adds to these published experiences by providing a formal
oncology-focused research curriculum within the CDH clinical oncology training program via a fully virtual platform,
demonstrating the feasibility of increasing research mentorship capacity through the inclusion of international peer
mentors.
One limitation of our study is that it was conducted at a
single center in Sub-Saharan Africa, and the findings may
not be generalizable to other African countries or LMICs.
Nevertheless, participants in the program were from countries throughout Sub-Saharan Africa and responded similarly to the content, suggesting that the lessons learned are
relevant in other settings. The training program described
is still nascent, and the long-term impact on trainee
research perceptions and development, career trajectory,
and research productivity could not be captured. The interviews were conducted by an MDA team member who did
not participate in the program or previously interact with
the participants, but responses could have been biased to
demonstrate an interest in research due to social desirability bias. Although our sample size was modest (n = 13),
our response rate was high (93%) and data saturation was
reached.17 The viewpoints reflected here are only of trainee
participants, and future studies examining the perspectives
of other stakeholders such as local and international mentors and institutional leaders may complement this data.

Conclusion
Significant disparities still exist in cancer research output globally, despite a trend toward higher cancer burdens in LMICs,
especially within Sub-Saharan Africa.18 Developing collaborative,
virtual clinical research training partnerships between academic
medical centers with strong clinical research infrastructure and
resource-constrained centers will be important in the coming years
to increase research capacity and address this gap, especially as
COVID-19 has resulted in greater acceptance and feasibility of virtual partnerships.19 The perspectives of Zambian clinical oncology
trainees participating in MOZART demonstrate a strong interest
in clinical research, the unique and important role of international
peer mentors as a potential source of increased mentorship capacity, the importance of longitudinal programs with early exposure
of trainees to clinical research, and the challenges specific to performing clinical research as a trainee in a resource-constrained
environment. The lessons learned can inform the development
and scale-up of clinical research initiatives for other African clinical oncology trainees.
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a facilitator have been developed in response.8 However, the
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infrastructure may be particularly important for increasing
mentorship capacity and should be further explored and
leveraged. Some of the potential benefits of peer mentorship
found here were better availability and approachability compared with faculty mentors, and the mutual benefit to the peer
mentors of having global health opportunities that may shape
their own career trajectories. The trainees in our program
expressed high satisfaction with the relationships formed
and time spent with their peer mentors. In a family medicine
training program in Lesotho, international peer mentorship
led to increased research confidence over time, but both the
participants and international peer mentors themselves noted
insufficient research expertise, highlighting the importance of
a mixed-peer and faculty mentorship team and involving peer
mentors with significant prior clinical research experience.9
Programs considering international peer mentors could consider entry criteria such as having peer-reviewed publications,
prior mentoring experience, and/or mentorship training.
The trainees described unique challenges inherent to conducting research in resource-constrained environments, such
as frequent personal illness, lack of high quality health data
or access to journal articles, and insufficient time for research
owing to high clinical demands.10 These underscore the
importance of a longitudinal research program that accounts
for these and other factors that tend to increase the amount
of time required to learn clinical research skills and complete
research projects, while “workshop” type single-instance initiatives may be less effective.
While these barriers to clinical research are complex,
there are some potential solutions. Trainees in LMICs
may have free access to a wide array of biomedical and
health literature through Research4Life.11 A prospective
breast and cervical cancer database of patients treated at
CDH has been developed through external grant funding
to CDH (PI: S.C.M.) and will be expanded through joint
efforts. Providing protected research time for trainees is difficult given the inherent shortage of healthcare providers,
but CDH leadership is committed to providing protected
time apart from clinical duties for trainees to participate
in MOZART. Some programs have hired general clinical
associates to handle routine clinical tasks so that oncology
trainees have dedicated research time.12
Other North-South research training collaborations include
CARTA,13 ARCADE,14 WHO/TDR,15 and MEPI-MESAU,16
among others. For the most part, these programs focus on
doctoral-level researchers, are not specific to oncology, and
require a competitive application process. However, the success of these programs, which have improved progress on
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